Cancer Fatalism Among Asian American Adults by Origin Group, 2012–2022

IF 2.9 2区医学 Q2 ONCOLOGY

Cancer Medicine Pub Date : 2025-03-18 DOI:10.1002/cam4.70738

Justine Liu, Yenan Zhu, Ryan Suk, Milkie Vu

{"title":"Cancer Fatalism Among Asian American Adults by Origin Group, 2012–2022","authors":"Justine Liu, Yenan Zhu, Ryan Suk, Milkie Vu","doi":"10.1002/cam4.70738","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Backgrounds</h3>\n \n <p>Cancer fatalism, the belief that cancer is predetermined and unpreventable, is associated with lower uptake of cancer prevention. Little is known about cancer fatalism prevalence within various Asian origin groups.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>We conducted a disaggregated analysis of cancer fatalism among Chinese, Filipino, Indian, Vietnamese, and other Asian respondents using the 2012–2022 Health Information National Trends Survey. Pairwise comparisons were conducted to assess differences between each racial and ethnic group.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Significantly lower proportions of Indian respondents (40.36%) endorsed the statement “It seems like everything causes cancer,” when compared with Vietnamese (74.59%, p = 0.0002) and Filipino (75.18%, p = 0.0009) respondents. Lower proportions of Indian and Chinese respondents endorsed the statement “There's not much you can do to lower your chances of getting cancer” when compared with Vietnamese and Filipino respondents, though these differences were not significant.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Findings highlight the heterogeneity among Asian origin groups and emphasize the importance of disaggregated data collection by origin group, which can inform culturally tailored interventions.</p>\n </section>\n </div>","PeriodicalId":139,"journal":{"name":"Cancer Medicine","volume":"14 6","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cam4.70738","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cam4.70738","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Backgrounds

Cancer fatalism, the belief that cancer is predetermined and unpreventable, is associated with lower uptake of cancer prevention. Little is known about cancer fatalism prevalence within various Asian origin groups.

Methods

We conducted a disaggregated analysis of cancer fatalism among Chinese, Filipino, Indian, Vietnamese, and other Asian respondents using the 2012–2022 Health Information National Trends Survey. Pairwise comparisons were conducted to assess differences between each racial and ethnic group.

Results

Significantly lower proportions of Indian respondents (40.36%) endorsed the statement “It seems like everything causes cancer,” when compared with Vietnamese (74.59%, p = 0.0002) and Filipino (75.18%, p = 0.0009) respondents. Lower proportions of Indian and Chinese respondents endorsed the statement “There's not much you can do to lower your chances of getting cancer” when compared with Vietnamese and Filipino respondents, though these differences were not significant.

Conclusions

Findings highlight the heterogeneity among Asian origin groups and emphasize the importance of disaggregated data collection by origin group, which can inform culturally tailored interventions.

Abstract Image

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Cancer Medicine ONCOLOGY-

CiteScore

5.50

自引率

2.50%

发文量

907

审稿时长

19 weeks

期刊介绍： Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research from global biomedical researchers across the cancer sciences. The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas: Clinical Cancer Research Translational research ∙ clinical trials ∙ chemotherapy ∙ radiation therapy ∙ surgical therapy ∙ clinical observations ∙ clinical guidelines ∙ genetic consultation ∙ ethical considerations Cancer Biology: Molecular biology ∙ cellular biology ∙ molecular genetics ∙ genomics ∙ immunology ∙ epigenetics ∙ metabolic studies ∙ proteomics ∙ cytopathology ∙ carcinogenesis ∙ drug discovery and delivery. Cancer Prevention: Behavioral science ∙ psychosocial studies ∙ screening ∙ nutrition ∙ epidemiology and prevention ∙ community outreach. Bioinformatics: Gene expressions profiles ∙ gene regulation networks ∙ genome bioinformatics ∙ pathwayanalysis ∙ prognostic biomarkers. Cancer Medicine publishes original research articles, systematic reviews, meta-analyses, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper.